SAGE Therapeutics Inc (NASDAQ:SAGE)
| 19.73 BATS BZX Real-Time Price As of 11:24am ET |  -0.27 / -1.35%Today’s Change | 16.52 Today|||52-Week Range 59.99 | -48.27% Year-to-Date |
Latest SAGE News | Press Releases
| Why Is Sage Therapeutics, Inc. (SAGE) Up 12.7% Since Last Earnings Report? Dec 07 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 20.00 |
| Today’s open | 19.80 |
| Day’s range | 19.40 - 19.87 |
| Volume | 12,646 |
| Average volume (3 months) | 1,195,407 |
| Market cap | $1.2B |
Data as of 11:24am ET, 12/11/2023
Growth & Valuation
| Earnings growth (last year) | -15.11% |
| Earnings growth (this year) | +13.04% |
| Earnings growth (next 5 years) | +24.79% |
| Revenue growth (last year) | +21.85% |
| P/E ratio | NM |
| Price/Sales | 294.29 |
| Price/Book | 0.95 |
Competitors
| ---- | ||
| ARDXArdelyx Inc | -0.17 | -3.15% |
| KNSAKiniksa Pharmaceutic... | -0.49 | -2.84% |
| VRNAVerona Pharma PLC | -0.54 | -3.69% |
Data as of 11:28am ET, 12/11/2023
Financials
| Next reporting date | February 22, 2024 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $7.7M |
| Annual profit (last year) | -$532.8M |
| Net profit margin | -6,931.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
